Petrus Trust Company, Lta Castle Biosciences Inc Transaction History
Petrus Trust Company, Lta
- $949 Million
- Q3 2024
A detailed history of Petrus Trust Company, Lta transactions in Castle Biosciences Inc stock. As of the latest transaction made, Petrus Trust Company, Lta holds 12,526 shares of CSTL stock, worth $338,953. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,526
Previous 12,526
-0.0%
Holding current value
$338,953
Previous $272,000
31.25%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
202Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$82.4 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$49.4 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$47.3 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$34.2 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$34 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $712M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...